STORIES
Each Suspicious Sample Tells a Story…
As Advisor on Lilly’s Global Product Protection Technical Team, Mike Dalton oversees technical personnel who conduct authentication testing of samples of suspected counterfeit medicines. The Global Product Protection Technical Team serves as one piece of an integrated network of experts inside and outside of Lilly work as a cohesive unit to stop pharmaceutical counterfeiting. Each suspected counterfeit medicine tells a story. It can tell you about where counterfeiting originates, where they are distributed around the Read more…
PRESS RELEASES & STATEMENTS
Internet Sales and Access to Safe Medicines – Joint Industry Statement
As more and more patients look to the Internet for the supply of medicines, IFPMA, PhRMA, EFPIA, and JPMA are united in the effort to protect their safety. We are committed to promoting access to safe and efficacious medicines, advocating for robust patient education and awareness, and combating unsafe medicines, including those sold by illegitimate online drug sellers that circumvent laws, regulations and pharmacy standards put in place to protect patients and their health. Download Read more…
INFORMATIONAL MATERIALS
Nurses Target Fake Medicines: Information and Action Tool Kit
ICN: Nurses target fake medicines to inform nurses and to provide them with the tools to tackle this growing problem. Download the information and action toolkit. ICN : Le crime des contrefaçons – Les infirmières ciblent les faux médicaments. Télécharger le dossier d’information et d’action.
INFORMATIONAL MATERIALS
Study Report IRACM Counterfeit Medicines and Criminal Organisations
IRACM Study Report on Counterfeit Medicines and Criminal Organizations: download it. Rapport d’Etude de l’IRACM sur la Contrefacon de Medicaments et les Organisations Criminelles : téléchargez-le ici (French link).
INFORMATIONAL MATERIALS
Medicines Quality Database Terms
Concerns about the availability of substandard and counterfeit medicines prompted USAID and PQM to establish Medicines Quality Monitoring (MQM) programs in Africa, Asia, Eastern Europe, and Latin America and the Caribbean to mitigate the significant negative impact of their use on the public’s health. This online Medicines Quality Database (MQDB) contains the results of MQM activities coordinated by PQM and local stakeholders. To visit the Medicines Quality Database (MQDB)click here.
INFORMATIONAL MATERIALS
Nurses Target Fake Medicines Poster
ICN: Nurses target fake medicines to inform nurses and to provide them with the tools to tackle this growing problem. Download the poster here. ICN : Le crime des contrefaçons – Les infirmières ciblent les faux médicaments. Télécharger le poster ici (French link). ICN : Las falsificaciones matan – Las enfermeras, contra los medicamentos falsificados y de baja calidad. Descarga el poster aquí.
INFORMATIONAL MATERIALS
IFPMA – Falsified Medicines and the Global Public’s Health Study
University College London (UCL) School of Pharmacy and the international research agency Matrix Insight study on the threats posed by falsified medicines and need for better coordinated global approaches to protect public health: the study highlights opportunities for a better coordinated international response to the threat of falsified medicines. The prevention of pharmaceutical falsification should be seen as an integral part of the global health community’s effort to improve access to effective, good quality medicines and protect Read more…
UPDATES
New Database Compiles Key Anti-Counterfeiting Systems
The Institute of Research Against Counterfeit Medicines (IRACM) has published a new online database, home to over 100 key technologies that can be used in the fight against counterfeit medicines. These systems include those used to authenticate, identify and trace products and use innovations such as holograms, code bubbles and data matrices. IRACM has also analysed the relevance of these anti-counterfeiting systems to the fight against fake medicines, providing quality/price ratios for stakeholders such as Read more…